Regenstrief Institute investigator recognized as a Top New Geriatrics Investigator

March 26th, 2012
Regenstrief Institute investigator Noll Campbell, PharmD is an Indiana University Center for Aging Research center scientist, a research assistant professor in the Department of Pharmacy Practice, Purdue University College of Pharmacy, and clinical pharmacy specialist in geriatrics with Wishard Health Services. Credit: Regenstrief Institute, Inc.
Regenstrief Institute investigator Noll Campbell, PharmD, has been chosen by the American Geriatrics Society to receive a Merck/American Geriatrics Society 2012 New Investigator Award. He is the first doctor of pharmacy to receive this award, which is designed to recognize individuals who are committed to a career in aging research.

This recognition is presented to individuals whose original research reflects new and relevant work in geriatrics. The award will be presented at the AGS annual scientific meeting in Seattle in May.

"Noll Campbell is a rising young pharmacoepidemiologist dedicated to improving the lives of older adults. His clinical research into the negative effects of many medications on the aging brain has impressed and influenced other investigators both in the country and abroad," said Regenstrief Institute investigator Malaz Boustani, M.D., MPH, associate professor of medicine at the Indiana University School of Medicine and associate director of the IU Center for Aging Research. Dr. Boustani is also the medical director of the Healthy Aging Brain Center at Wishard Health Services.

In addition to his Regenstrief appointment, Dr. Campbell is a research assistant professor in the Department of Pharmacy Practice, Purdue University College of Pharmacy, and clinical pharmacy specialist in geriatrics with Wishard Health Services. Wishard is one of the largest public hospital systems in the United States.

"Few graduates of pharmacy schools progress to the clinical proficiency that Dr. Campbell possesses, and even fewer develop that interest to pursue clinical research. His early success in the research environment strongly suggests that his work will fill important gaps in the clinical literature and improve the care of a frail population," said Regenstrief Institute investigator Michael Murray, PharmD, MPH, Distinguished Professor and Endowed Chair of Medication Safety, Purdue University College of Pharmacy. Dr. Murray is also the executive director of the Regenstrief Center for Healthcare Improvement and Research.

Provided by Indiana University School of Medicine

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Facial features are the key to first impressions

A new study by researchers in the Department of Psychology at the University of York shows that it is possible to accurately predict first impressions using measurements of physical features in everyday images of faces, such ...

Cell's recycling center implicated in division decisions

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

Gender disparities in cognition will not diminish

The study, published in the Proceedings of the National Academy of Science, investigated the extent to which improvements in living conditions and educational opportunities over a person's life affect cognitive abilities and th ...

Lenovo's smart glasses prototype has battery at neck

China's PC giant Lenovo last week offered a peek at its Google Glass-competing smart glass prototype, further details of which are to be announced in October. Lenovo's glasses prototype is not an extreme ...